CLGN NASDAQ
CollPlant Biotechnologies Ltd.
1W: -19.5%
1M: -0.3%
3M: -20.1%
YTD: -76.9%
1Y: -86.5%
3Y: -93.9%
5Y: -97.9%
$3.46
-0.11 (-3.08%)
Weekly Expected Move ±15.0%
$2
$3
$3
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$11M
-42.4% ▼
5Y CAGR: -0.1%
Total Liabilities
$5M
-10.3% ▼
5Y CAGR: -5.9%
Shareholders Equity
$6M
-54.8% ▼
5Y CAGR: +6.3%
Cash & Investments
$6M
-50.0% ▼
5Y CAGR: +12.3%
Total Debt
$3M
-7.6% ▼
5Y CAGR: -3.4%
Net Debt
-$3M
+64.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $13M | $30M | $27M | $12M | $6M |
| Short-Term Investments | $30M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $43M | $30M | $27M | $12M | $6M |
| Net Receivables | $270K | $9K | $393K | $583K | $1K |
| Inventory | $1M | $1M | $714K | $440K | $573K |
| Other Current Assets | $437K | $566K | $241K | $248K | $223K |
| Total Current Assets | $45M | $32M | $28M | $13M | $7M |
| Property, Plant & Equip. | $6M | $6M | $6M | $5M | $4M |
| Goodwill & Intangibles | $243K | $245K | $188K | $131K | $73K |
| Long-Term Investments | $0 | $188K | $57K | $118K | $76K |
| Other Non-Current Assets | $426K | $188K | $0 | $0 | $0 |
| Total Non-Current Assets | $6M | $6M | $6M | $6M | $4M |
| Total Assets | $51M | $38M | $34M | $19M | $11M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $1M | $980K | $870K | $610K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $814K |
| Deferred Revenue | $32K | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $566K | $499K | $2M | $1M | $1M |
| Total Current Liabilities | $3M | $3M | $3M | $3M | $3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $3M | $2M | $3M | $2M | $2M |
| Total Liabilities | $6M | $5M | $6M | $5M | $5M |
| — Equity — | |||||
| Common Stock | $5M | $5M | $5M | $5M | $5M |
| Retained Earnings | -$73M | -$90M | -$97M | -$113M | -$125M |
| Accumulated OCI | -$969K | -$969K | -$969K | -$969K | -$969K |
| Total Stockholders Equity | $45M | $32M | $28M | $13M | $6M |
| Total Liabilities & Equity | $51M | $38M | $34M | $19M | $11M |
| — Key Metrics — | |||||
| Total Debt | $4M | $3M | $3M | $3M | $3M |
| Net Debt | -$10M | -$27M | -$24M | -$9M | -$3M |
| Total Investments | $30M | $188K | $57K | $118K | $76K |